Our results suggested that FBP1 was downregulated in ovarian cancer and that this could be related to tumor progression; therefore, next we aim to investigate the mechanisms of FBP1 downregulation in this type of cancer. The gene discussed is FBP1; the disease is ovarian carcinoma.